Publication | Closed Access

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

VaccinationRespiratory Virus ImmunityPediatricsRespiratory InfectionPediatric Lung DiseaseInfectious Respiratory DiseasePulmonary MedicineMedicineDouble-blind Placebo-controlled TrialPhase 3